Infusion

Influencer Media Group Infuse Follows Up on Stellar 2023 Growth with New Partnership, Podcast Launch, and Influencer Events

Retrieved on: 
Wednesday, April 3, 2024
Internet, Environment, Partnership, Electronic Arts, Fluency, Samsung, Content, Culture, Infusion, Uber, Podcast, Tourism

This partnership underscores Infuse's commitment to fostering influencer talent and maximizing their potential in the dynamic landscape of influencer marketing.

Key Points: 
  • This partnership underscores Infuse's commitment to fostering influencer talent and maximizing their potential in the dynamic landscape of influencer marketing.
  • As a Fluent brand, Infuse opens up numerous integrated marketing opportunities for influencers through Fluent’s fifteen-year track record as a performance marketing leader.
  • A highlight of this collaboration is the launch of the "Cater 2 the Creator" podcast, a joint venture between Infuse and THIS Group.
  • The two teams will attend industry events together, seeking mutually beneficial opportunities for their shared influencer clients.

Azuca Takes the Fast Lane with Infusions in the Hemp Cannabinoid Market Through Strategic Collaboration with Open Book Extracts

Retrieved on: 
Thursday, April 4, 2024
RTD, Absorption, CGMP, Inhalation, Titan Mare Explorer, Infusion, OBX, NSF, Drink, B2B, Chocolate, THC

NEW YORK, April 4, 2024 /PRNewswire/ -- Azuca, a trailblazer in advanced infusions within the regulated cannabis market, today announced a strategic collaboration with leading cannabinoid ingredient and product manufacturer Open Book Extracts (OBX) for the burgeoning hemp market, inclusive of federally-compliant, hemp-derived delta-9 THC.

Key Points: 
  • This collaboration harnesses Azuca's innovative TiME INFUSION® process and ACTiVATOR® product line with OBX's expertise in cannabinoid ingredients, product development, and finished goods manufacturing.
  • Positioned as a "fast track" solution, Azuca and OBX will offer brands and manufacturers a streamlined pathway from concept to market, significantly reducing the time it takes to reach consumers.
  • "At Azuca, we are dedicated to pushing the boundaries of innovation to deliver efficient, reliable, and delicious cannabis experiences for consumers.
  • "Open Book Extracts is committed to making products that work for brands that care," shares Nicole Brown, OBX Chief Innovation Officer.

Medix Infusion Announces the Appointment of Pavlos Pavlidis, Jr., President and Chief Operating Officer

Retrieved on: 
Monday, January 29, 2024
UnitedHealth Group, Culture, Biotechnology, Biogen, Infusion, History, Medco, Ohio State University, Nursing, Organizational culture, Biopharmaceutical, McKesson Corporation

ADDISON, Texas, Jan. 29, 2024 /PRNewswire-PRWeb/ -- As Medix Infusion's new President and COO, Pav will lead and scale the company's multi-state business operations including Nursing, Pharmacy, Procurement, Business Insights and other operational departments that support the Company's 40 locations across 5 states. Since the end of 2020 Medix has grown nearly 600%, expanded manufacturer partnerships and established itself as a leader in infusion care. "Pav brings decades of leadership and operations experience in specialty pharmacy, biotechnology, and patient support services, as well as exceptional physician and patient advocacy focus. Execution without compromising, our team culture will be essential as Medix looks to continue to grow as a national leader, and Pav has an impressive history of developing efficiencies while developing, coaching, and successfully impacting organizational culture. We are delighted to have someone of Pav's caliber and reputation join our mission, and we look forward to his contributions in the next phase of the Company's growth," said CEO Gus de Avillez.

Key Points: 
  • Medix Infusion, a leader in the infusion industry, announced that Pavlos "Pav" Pavlidis has been appointed Medix's new President and Chief Operating Officer.
  • Since the end of 2020 Medix has grown nearly 600%, expanded manufacturer partnerships and established itself as a leader in infusion care.
  • Prior to joining Medix Infusion, Pav served as Chief Operating Officer at Biologics by McKesson.
  • Pav had many other notable leadership roles, including President & Chief Operating Officer at AppianRx, VP at UnitedHealth Group, Sr. Director at Biogen, VP and General Manager at Medco.

Infusion for Health Achieves Accreditation In Nevada, Colorado, Arizona and Washington with ACHC

Retrieved on: 
Friday, December 22, 2023
Patient, Wi-Fi, Pharmacy, ISO 9001:2015, Physician, Crohn's disease, Anemia, Accreditation, CIDP, Prescription, Drink, Infusion, Patient safety, Rheumatoid arthritis, Snack, Nursing, Chronic inflammatory demyelinating polyneuropathy, ACHC, Insurance, Hospice, Safety, Psoriasis, CMS, Environment

Brea, California--(Newsfile Corp. - December 22, 2023) - Infusion for Health proudly announces it has achieved accreditation through Accreditation Commission for Health Care (ACHC) for the services of infusion therapy for its locations in Nevada, Colorado, Arizona and Washington, with California locations scheduled to have accreditation complete in Q1 2024.

Key Points: 
  • Brea, California--(Newsfile Corp. - December 22, 2023) - Infusion for Health proudly announces it has achieved accreditation through Accreditation Commission for Health Care (ACHC) for the services of infusion therapy for its locations in Nevada, Colorado, Arizona and Washington, with California locations scheduled to have accreditation complete in Q1 2024.
  • Accreditation by ACHC reflects an organization's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.
  • As Dan McCarty, CEO of Infusion for Health says, "This accreditation is a testament to our commitment to clinical excellence and exceptional care for our patients.
  • ACHC accreditation marks a major milestone for Infusion for Health, which opened its first outpatient infusion center in 2015 in Thousand Oaks, CA.

CONCENTRIC EQUITY PARTNERS ANNOUNCES INVESTMENT IN INFUSION MARKETING

Retrieved on: 
Monday, December 18, 2023
Marketing, Entrepreneurship, Partnership, Infusion, CEP, Risk management

CHICAGO, Dec. 18, 2023 /PRNewswire/ -- Concentric Equity Partners ("CEP") announced the partnership with Infusion Marketing Group, LLC ("Infusion" or the "Company"), a provider of data-driven analytics and marketing services for banks and credit unions.

Key Points: 
  • CHICAGO, Dec. 18, 2023 /PRNewswire/ -- Concentric Equity Partners ("CEP") announced the partnership with Infusion Marketing Group, LLC ("Infusion" or the "Company"), a provider of data-driven analytics and marketing services for banks and credit unions.
  • The Infusion Norm allows clients to benchmark against peer institutions and provides robust insights into strengths, weaknesses, and unique growth opportunities.
  • The Infusion Strategy Team has more than 100 combined years of banking, data analytics, and direct marketing experience.
  • We are excited to leverage our banking and marketing expertise to help Infusion expand its ability to serve community banks and credit unions better."

AIS Healthcare Recognized by Accreditation Commission for Health Care

Retrieved on: 
Tuesday, December 12, 2023
General Health, Pharmaceutical, Health, Accreditation, Specialty pharmacy, Infusion, Commission, Patient safety, Patient, ACHC, TDD, Nursing

AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers.

Key Points: 
  • AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it is has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy, and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), an internationally recognized accrediting body, further setting it apart from other infusion services providers.
  • Formed in 1986, the Accreditation Commission for Health Care grants accreditation for providers in the home care and home infusion therapy industries.
  • Accreditation also helps providers like AIS Healthcare to demonstrate their ability to meet official regulatory requirements and standards, resulting in a higher level of performance and a greater focus on patient care.
  • Thank you to ACHC for this important recognition and to the entire team at AIS Healthcare for their dedication to the patients we serve,” said Simon Castellanos, AIS Healthcare CEO.

Targo Chooses IP Infusion For Upgraded Backbone Network

Retrieved on: 
Monday, November 13, 2023
Software, Networks, Internet, Hardware, Data Management, Technology, Carriers and Services, Mobile, Wireless, GPON, Ubiquiti, Infusion, MikroTik, BGP, VXLAN, Cisco, ISP, Targe

IP Infusion , the market leader in carrier-grade networking software systems, announced today that Montreal-based Internet service provider Targo has implemented IP Infusion OcNOS® software and hardware from UfiSpace and Edgecore Networks to upgrade and service their backbone network.

Key Points: 
  • IP Infusion , the market leader in carrier-grade networking software systems, announced today that Montreal-based Internet service provider Targo has implemented IP Infusion OcNOS® software and hardware from UfiSpace and Edgecore Networks to upgrade and service their backbone network.
  • Targo built their fiber network with Gigabit Passive Optical Networking (GPON).
  • “OcNOS has been a little surprising with its combination of features and cost,” said Michel Blais, Network Architect for Targo.
  • “IP Infusion continues to offer a feature list on par with other networking vendors without sacrificing performance for immediate ROI.”

Smileyscope Therapy is the First Virtual Reality Device to Receive FDA Class II Clearance for Acute Pain

Retrieved on: 
Monday, November 6, 2023
Digital, Class II, FDA, VR, Child, Standard of care, History, American Medical Association, Infusion, Medicine, Virtual reality, Hospital, Pain, Digital therapeutics, Safety, Anxiety, Therapy, Patient, Class, Marketing, Nursing, Pharmaceutical industry, Medical device

WASHINGTON, Nov. 6, 2023 /PRNewswire-PRWeb/ -- The FDA has granted Class II clearance to Smileyscope™ Therapy, making Smileyscope Therapy the first and only VR Analgesic™ available in the US. Smileyscope is the premier provider of drug-free pain and anxiety treatments for procedures, worldwide.

Key Points: 
  • Smileyscope has made history by becoming the first virtual reality (VR) device to receive FDA Class II clearance for acute pain.
  • This approval recognizes Smileyscope's innovative Procedural Choreography™ technique, which uses positive virtual stimuli to reduce pain and anxiety during medical procedures.
  • WASHINGTON, Nov. 6, 2023 /PRNewswire-PRWeb/ -- The FDA has granted Class II clearance to Smileyscope™ Therapy, making Smileyscope Therapy the first and only VR Analgesic™ available in the US.
  • Smileyscope's studies, the world's largest randomized trials in procedural VR, were reviewed by the FDA during the Class II filing.

Provident Healthcare Partners Advises Nightingale Services, Infusion, and Pharmacy in its Partnership with Honor Health Network

Retrieved on: 
Wednesday, November 1, 2023
Patient, Acquisition, Partnership, Heather Brooke, Nursing, Hospital, Pharmacy, Common nightingale, Infusion

BOSTON and NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Nightingale Services, Infusion, and Pharmacy ("Nightingale") in its partnership with Honor Health Network, a portfolio company of Webster Equity Partners.

Key Points: 
  • BOSTON and NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Nightingale Services, Infusion, and Pharmacy ("Nightingale") in its partnership with Honor Health Network, a portfolio company of Webster Equity Partners.
  • Nightingale is a leading provider of home care services in Georgia, offering personal care, skilled nursing, infusion, and pharmacy services.
  • Provident Healthcare Partners Advises Nightingale Services, Infusion, and Pharmacy in its Partnership with Honor Health
    Provident's deal team was led by Managing Director Kevin Palamara and Vice President Jake Vesely .
  • Bouhan Falligant served as legal counsel to Nightingale and Goodwin Procter served as legal counsel to Honor Health Network.

NTT DATA and IP Infusion Partner to Accelerate Network Disaggregation

Retrieved on: 
Tuesday, October 10, 2023
Technology, Mobile, Wireless, Carriers and Services, Telecommunications, Software, Networks, Internet, Hardware, Data Management, IP, Partnership, Cisco, DATA, NTT, NTT DATA, Data center, Telecom Infra Project, Infusion, Cassini, DCSG, Juniper, Telecom, OOPT, LATAM, TIP, NOS, Gigaom, Mobile phone, Network equipment provider

NTT DATA and IP Infusion are collaborating for go-to-market open networking solutions to bring enhanced disaggregation, scalability, and choices to network operators.

Key Points: 
  • NTT DATA and IP Infusion are collaborating for go-to-market open networking solutions to bring enhanced disaggregation, scalability, and choices to network operators.
  • NTT DATA will offer IP Infusion Cell Site Routers, Routed Optical Networking, Aggregation Router and Data Center software products, including bundled solutions, on a broad portfolio of white box hardware.
  • “We are deeply committed to accelerating network disaggregation throughout our global ecosystem of customers and partners,” said Teodoro López Palacios, Partner, Telecom Sector at NTT DATA Europe & LATAM.
  • “NTT DATA and IP Infusion have long demonstrated deep expertise in open network solutions and this collaboration will help create a stronger, more flexible supply chain, supporting high-quality connectivity.”
    “We are pleased to partner with NTT DATA to drive further market penetration for open networking,” said Atsushi Ogata, President and CEO of IP Infusion.